Group One Trading
KNTE

Group One Trading’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Group One Trading’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,257,200
Closed -$3.34M – 7752
2024
Q1 		$3.34M Sell
1,257,200
-21,600
-2% -$53.5K 0.01% 1110
2023
Q4 		$3.03M Buy
1,278,800
+1,278,500
+426,167% +$2.26M 0.01% 1518
2023
Q3 		$420 Hold
300
– – ﹤0.01% 7363
2023
Q2 		$909 Buy
+300
New +$1.16K ﹤0.01% 7278

Group One Trading's KNTE Position: Q2 2024 in Review

Group One Trading sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 354,121 shares — an estimated $942K sold.

Group One Trading first reported a position in KNTE in Q2 2023 and held it in 4 quarters. The position peaked at $1.34M in Q4 2023. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

  • Group One Trading reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 354,121 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $942K.
  • Group One Trading first reported a position in Kinnate Biopharma Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Group One Trading's Kinnate Biopharma Inc. Common Stock position peaked at $1.34M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.